This Implementation Plan for the Antimicrobial Resistance National Strategy Framework, 2014 – 2024 aims to manage antimicrobial resistance and limit further increases in resistant microbial infections, and improve patient outcomes, ensuring the appropriate use of antimicrobials by health care professionals in all health establishments to conserve the efficacy of antibiotics for the optimal management of infections in human and animal health. The interventions included in the AMR strategy apply equally to antibiotics as they do to drug resistance in tuberculosis, HIV, and antifungals. The Implementation Plan has 3 specific aims (1) translate the antimicrobial resistance strategic framework, goals and objectives into activities that will have measurable outputs that can be monitored and evaluated; (2) ensure that all parties who have a stake in implementing AMR strategies understand how the strategy will be implemented and what their responsibilities are to be in relation to implementation; (3) clarify how the implementation of the Strategy will affect other programmes, managers, and stakeholders. This AMS Implementation Plan is structured around 5 strategic objectives (1) strengthen governance and coordination by institutionalising interdisciplinary antimicrobial stewardship efforts through effective governance structures at national, provincial, and healthcare establishment levels; (2) improve the use of diagnostics to support appropriate antimicrobial treatment by promoting the timely and appropriate selection and collection of specimens, accurate and timely laboratory testing, and prompt reporting and interpretation of results; (3) strengthen AMR surveillance and early detection to generate reliable local, regional, and national resistance data that can inform appropriate empiric and targeted antimicrobial selection; (4) strengthen infection prevention and control to reduce the transmission of resistant microorganisms in healthcare settings, with a particular focus on hand hygiene and the early identification and appropriate isolation of patients with resistant organisms. Prevention of infections through comprehensive vaccination programmes should also be promoted; (5) promote responsible antimicrobial use in both human and animal health through effective antimicrobial stewardship, supporting the appropriate selection, dosing, route, and duration of antimicrobial treatment. The key enablers of these strategic objectives are (1) legislative and policy reform for health systems strengthening to support the country and to enable control antimicrobials overprescribing in the animal and human health sector; (2) education at all levels of health providers in human health and agriculture in the critical concepts of antimicrobial stewardship, infection control, infectious diseases, microbiology, and pharmacology; (3) communication to educate the public, create awareness, and enhance patient advocacy of the dangers of inappropriate antimicrobial use and appropriate community measures to prevent infections; (4) research into novel diagnostics such as point-of-care testing and clinical trials of treatment duration, antimicrobial consumption plus new antimicrobials. Monitoring and evaluation aims to assess the extent to which the desired strategic objectives of the AMR National Strategic Framework have been achieved.
Южная Африка · 2015-09-01